PubMed HealthSearch

PubMed · 128670

[The objective frequency decrement test (OFDT): a new objective EEG-test for determination of the difference limen for frequencies (author's transl)].

Abstract

Subjective methods measuring the difference limen for frequencies (DLF) take a lot of time and are not reliable. You can find this fact not only while testing normal subjects, but also while testing patients with hearing loss combined with tinnitus. Therefore this new objective DLF-test has been developed. Apart from the testing function for clinical purpose, the different results of other studies can also be controlled. After 1080 msec a pure tone is changed to a lower frequency for a period of 670 msec. Immediately after the tone is finished a picture is presented. As a control pure tones of unvarying pitch are offered. This stimulus sequence is repeated for several times. The expectancies to the change of pitch and to the picture produce a negative slow potential shift (Walter's CNV) in the EEG. The perception of frequency change yields to a late evoked potential and to a DC-shift; as a result of the optimum conditions of the expectancy-situation and the appropriate recording-technique only 5-10 sweeps must be summed up to obtain a potential, sometimes it even can be seen in the "raw-EEG". The test makes a differentiation between a just believed and a real perception possible. A sample of subjects with normal hearing and a subgroup (musicians) were selected for the standardization. Because of objectivity, reliability and economy the test can be used for clinical application.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Brix. 1975. [The objective frequency decrement test (OFDT): a new objective EEG-test for determination of the difference limen for frequencies (author's transl)].. https://pubmed.ncbi.nlm.nih.gov/128670/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Visual acuity of low- and high-risk neonates and acuity development during the first year.

Binocular grating acuity of 65 neonates was measured using Teller acuity cards. At the time of testing, age corrected for prematurity ranged from -3 weeks to 2 weeks. On the basis of clinical data, serial ultrasound scans and EEG recording newborns were divided into 4 subgroups: fullterm low-risk (FLR, n = 22); preterm low-risk (PLR, n = 20); preterm medium-risk (PMR, n = 9) and preterm high-risk (PHR, n = 14). Mean visual acuity of PLR infants (0.86 cy/deg; S.D. 0.34 oct) was not significantly different from that of FLR newborns (0.80 cy/deg; S.D. 0.71 oct); the lower variability of the PLR infants might possibly be caused by their longer postnatal experience. Within the preterm groups, mean visual acuity of PLR newborns was found to be significantly higher than that of PMR (0.73 cy/deg; S.D. 0.26 oct) and PHR infants (0.73 cy/deg; S.D. 0.35 oct). This difference can not be explained by dissimilarities in postnatal or corrected age. Brain impairment, as documented by US scans and EEG recording could account for these findings. Longitudinal data are needed in order to substantiate these findings and correlate them with later neurological and neuro-imaging outcome. Preliminary results of an ongoing longitudinal study suggest acuity development of most, but not all, PHR infants, in whom a cystic-periventricular leukomalacia had been diagnosed, to be worse than that of low- and medium-risk infants.

Electroencephalography

Clinical value of polysomnography.

Polysomnography is used increasingly to investigate patients with possible sleep apnoea/hypopnoea syndrome (SAHS), but it has not been assessed critically. We thus examined prospectively the value of electrophysiological and respiratory monitoring in 200 consecutive adults (163 men, 37 women; mean [SD] age 50 [13] years) having polysomnography. At polysomnography, 91 patients had SAHS (greater than 15 apnoeas + hypopnoeas [A + H] per h asleep) and 11 had periodic limb-movement disorder. Recording sleep electrophysiologically was of no diagnostic value and SAHS could be as accurately defined by A + H per time in bed as by A + H per time asleep. 66% of patients with SAHS could be diagnosed with oximetry alone, but many of the undiagnosed patients had moderately severe SAHS and benefited from treatment. Neurophysiological sleep recording is unnecessary and oximetry alone is of limited value in the overnight investigation of patients suspected of having SAHS.

Electroencephalography